Sector revisions Legend Biotech Corporation

Equities

Real-time Estimate Cboe BZX Other stock markets 20:50:31 22/01/2026 GMT			5-day change	1st Jan Change
19.44 ^USD	-6.38%		-11.71%	-10.21%

01:08pm	TD Cowen Downgrades Legend Biotech to Hold From Buy, Adjusts Price Target to $21 From $62	MT
03:46am	Genscript Biotech Associate Books $555 Million in Q4 CARVYKTI Sales	MT

Add to a list 0 selected To use this feature you must be a member Log in Sign up	4m. EPS revision	4m. Revenue rev.	1y. EPS revision	1y. Revenue rev.	Visibility	Nbr of analysts
LEGEND BIOTECH CORPORATION						16
ARGENX SE						15
WUXI APPTEC CO., LTD.						18
INSMED INCORPORATED						18
BIONTECH SE						19
WUXI BIOLOGICS (CAYMAN) INC.						25
GENMAB A/S						13
AKESO, INC.						22
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.						17
SUMMIT THERAPEUTICS INC.						13
EXELIXIS, INC.						18
MADRIGAL PHARMACEUTICALS, INC.						14
SAMSUNG EPIS HOLDINGS CO., LTD.	-	-	-	-	-	1
ARROWHEAD PHARMACEUTICALS, INC.						11
NUVALENT, INC.						17
CYTOKINETICS, INCORPORATED						18
REMEGEN CO., LTD.						15
Average						16
Weighted average by Cap.						17